AIM (STOCKS)
AIM ImmunoTech Inc.
$0.260000
+0.003000 (+1.17%)
Prev close: $0.257000
Company Information
- Exchange
- XASE
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Thomas Kenwood Equels
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $7.77M
- Employees
- 23
- P/E (TTM)
- -0.07
- P/B (TTM)
- 0.96
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
1
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.43 | $-0.17 | -0.2583 | -150.44% |
|
Mar 2026 (Q1)
|
$-0.57 | $-0.37 | -0.1963 | -52.53% |
|
Dec 2025 (Q4)
|
$-1.44 | $-0.97 | -0.4663 | -47.89% |
|
Sep 2025 (Q3)
|
$-1.57 | $-0.98 | -0.5846 | -59.43% |
Financial Statements
| Assets | $22.11M |
| Current Assets | $14.44M |
| Inventory | $8.14M |
| Other Current Assets | $6.30M |
| Noncurrent Assets | $7.68M |
| Fixed Assets | $4.62M |
| Other Non-current Assets | $3.06M |
| Liabilities | $10.40M |
| Current Liabilities | $6.88M |
| Wages | $856.00K |
| Other Current Liabilities | $6.02M |
| Noncurrent Liabilities | $3.52M |
| Equity | $11.72M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $11.72M |
| Liabilities And Equity | $22.11M |